1-FLUOROCYCLOPROPANE-1-SULFONAMIDE, 95.0%, 100mg

7-Trifluoromethylisatin, 95.0%, 100g

4,4-Dimethyl-2-vinyloxazol-5(4H)-one, 95.0%, 1g

iso-Propyl 4-aminobenzoate, 98.0%, 50g

4-(Difluoromethoxy)-3-(cyclopropylmethoxy)benzaldehyde, 95.0%, 25g

2-Methyl-1-(4-nitrophenyl)-1H-imidazole, 95.0%, 5g

1-(tert-Butoxycarbonyl)-4-(4-fluorobenzyl)piperidine-4-carboxylic acid, 97%, 1g

4-Chloro-N-(cyclopropylmethyl)aniline hydrochloride, 97.0%, 250mg

7-METHOXYQUINOLIN-6-AMINE, 95.0%, 1g

BenzaMide, N-[4-[(4-ethyl-1-piperazinyl)Methyl]-3-(trifluoroMethyl)phenyl]-4-Methyl-3-[[[5-(2-thienyl)-3-pyridinyl]carbonyl]aMino]-, 98%, 10mg

GC capillary column ROTI®Cap-1, 50 m, 0.20 mm, 0.50 µm, 1 Piece(s)

2-(2-Methylphenyl)-4-phenylthiazole, 1g

butyl[(2E)-3-(2-methoxyphenyl)prop-2-en-1-yl]amine hydrochloride, 95.0%, 1g